PharmaCyte Biotech, Inc. Common Stock

PMCB us
$0.44
▼ 0.02 (-3.37%)
Volume: 399,473 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 19
  • 21d momentum -18.4%
  • MA aligned bearish
  • RSI 42
🎯 Pullback 50
  • -4.1% vs 20MA
💎 Value 58
  • -71% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)42.2
MACD+0.006
MA trendBearish
ATR10.15%
21d mom.-18.4%
63d mom.-42.7%
vs 20MA-4.1%
RVOL(20)1.04×
52w low · 0 52w high · 2
-70.8% from 52-week high
20d support 0 · resistance 1

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$5M
PER—
PBR0.18
PSR—
EPS$-3.35
ROE-130.6%
ROA-97.8%
Dividend yield6.67%
Debt/Equity0.00
EV/EBITDA1.45
week1M3M6M1YYTD
-4.07% -18.41% -42.70% -43.48% -58.79% -40.24%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
3/10
🐻 Bear
10/10

14d momentum -9.35%, daily vol 4.44%. PharmaCyte Biotech, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.